name,category,termsAIG2-like domain 1,INTERPRO[450008399$IPR009288:AIG2-like, 450011691$IPR013024:Butirosin biosynthesis, BtrG-like]
AIG2-like domain 1,PIR_SUPERFAMILY[630020204$PIRSF026437:troponin C protein, tina-1 type]
AIG2-like domain 1,SP_PIR_KEYWORDS[790000356$complete proteome]
AIG2-like domain 1,UP_SEQ_FEATURE[850004202$chain:AIG2-like domain-containing protein 1]
ATPase, Ca++ transporting, plasma membrane 4,INTERPRO[450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005830$IPR006408:ATPase, P-type, calcium-transporting, PMCA-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, plasma membrane 4,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway]
ATPase, Ca++ transporting, plasma membrane 4,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, plasma membrane 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000924$membrane protein, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001555$transmembrane, 790001558$transport]
ATPase, Ca++ transporting, plasma membrane 4,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850039441$chain:Plasma membrane calcium-transporting ATPase 4, 850102572$compositionally biased region:Poly-Glu, 850102577$compositionally biased region:Poly-Lys, 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850111170$region of interest:Calmodulin-binding subdomain A, 850111171$region of interest:Calmodulin-binding subdomain B, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
ATPase, H+ transporting, lysosomal V0 subunit a1,INTERPRO[450002209$IPR002490:ATPase, V0/A0 complex, 116-kDa subunit]
ATPase, H+ transporting, lysosomal V0 subunit a1,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038840$hsa04142:Lysosome, 470038896$hsa05110:Vibrio cholerae infection, 470038897$hsa05120:Epithelial cell signaling in Helicobacter pylori infection]
ATPase, H+ transporting, lysosomal V0 subunit a1,PIR_SUPERFAMILY[630001439$PIRSF001293:V-type ATPase subunit]
ATPase, H+ transporting, lysosomal V0 subunit a1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000739$Hydrogen ion transport, 790000798$ion transport, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane, 790001558$transport]
ATPase, H+ transporting, lysosomal V0 subunit a1,UP_SEQ_FEATURE[850099766$chain:V-type proton ATPase 116 kDa subunit a isoform 1, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
B-cell CLL/lymphoma 7A,INTERPRO[450006210$IPR006804:BCL7, N-terminal]
B-cell CLL/lymphoma 7A,OMIM_DISEASE[520000500$B-cell non-Hodgkin lymphoma, high-grade]
B-cell CLL/lymphoma 7A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
B-cell CLL/lymphoma 7A,UP_SEQ_FEATURE[850007046$chain:B-cell CLL/lymphoma 7 protein family member A, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
CASP8 and FADD-like apoptosis regulator,BBID[10000060$36.Death_of_Key_Intracellular_Targets, 10000108$86.Apoptosis_Nematode&_Vert]
CASP8 and FADD-like apoptosis regulator,BIOCARTA[30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation]
CASP8 and FADD-like apoptosis regulator,INTERPRO[450001153$IPR001309:Peptidase C14, ICE, catalytic subunit p20, 450001658$IPR001875:Death effector, 450002131$IPR002398:Peptidase C14, caspase precursor p45, 450010009$IPR011029:DEATH-like, 450010431$IPR011600:Peptidase C14, caspase catalytic, 450014334$IPR015917:Peptidase C14, caspase precursor p45, core]
CASP8 and FADD-like apoptosis regulator,KEGG_PATHWAY[470038843$hsa04210:Apoptosis]
CASP8 and FADD-like apoptosis regulator,PIR_SUPERFAMILY[630029212$PIRSF037643:Casp8 and Fadd-like apoptosis regulator/caspase, types 8/10, 630030829$PIRSF500657:Casp8 and Fadd-like apoptosis regulator]
CASP8 and FADD-like apoptosis regulator,SMART[760000023$SM00031:DED, 760000102$SM00115:CASc]
CASP8 and FADD-like apoptosis regulator,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000733$host-virus interaction, 790001212$polymorphism, 790001304$repeat]
CASP8 and FADD-like apoptosis regulator,UP_SEQ_FEATURE[850009799$chain:CASP8 and FADD-like apoptosis regulator subunit p12, 850009800$chain:CASP8 and FADD-like apoptosis regulator subunit p43, 850103512$domain:DED 1, 850103513$domain:DED 2, 850105852$helix, 850106259$mutagenesis site, 850111188$region of interest:Caspase, 850112147$region of interest:Interaction with caspase-3, 850112149$region of interest:Interaction with caspase-8, 850112150$region of interest:Interaction with caspase-8 propeptide, 850112151$region of interest:Interaction with caspase-8 subunits p18 and p10, 850112316$region of interest:Interaction with FADD, 850112968$region of interest:Interaction with TRAF1 and TRAF2, 850113791$region of interest:Not proteolytically processed and involved in apoptosis inhibition, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
DNA-damage-inducible transcript 3,BIOCARTA[30000215$h_p38mapkPathway:p38 MAPK Signaling Pathway ]
DNA-damage-inducible transcript 3,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010528$IPR011700:Basic leucine zipper, 450014991$IPR016670:DNA damage-inducible transcript 3]
DNA-damage-inducible transcript 3,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
DNA-damage-inducible transcript 3,OMIM_DISEASE[520003538$Myxoid liposarcoma]
DNA-damage-inducible transcript 3,PIR_SUPERFAMILY[630013356$PIRSF016571:C/EBPzeta_CHOP_DDIT3]
DNA-damage-inducible transcript 3,SMART[760000306$SM00338:BRLZ]
DNA-damage-inducible transcript 3,SP_PIR_KEYWORDS[790000258$cell cycle, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000466$dna-binding, 790000631$growth arrest, 790001065$nucleus, 790001212$polymorphism, 790001271$Proto-oncogene, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
DNA-damage-inducible transcript 3,UP_SEQ_FEATURE[850015529$chain:DNA damage-inducible transcript 3, 850102572$compositionally biased region:Poly-Glu, 850104712$domain:Leucine-zipper, 850117294$sequence conflict, 850117295$sequence variant]
FKSG83,INTERPRO[450003588$IPR004072:Vomeronasal receptor, type 1]
G protein-coupled receptor 17,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450002032$IPR002286:P2 purinoceptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 17,PIR_SUPERFAMILY[630030123$PIRSF038619:uracil nucleotide/cysteinyl leukotriene receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 17,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
G protein-coupled receptor 17,UP_SEQ_FEATURE[850099571$chain:Uracil nucleotide/cysteinyl leukotriene receptor, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G-protein signaling modulator 2 (AGS3-like, C. elegans),INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450002733$IPR003109:GoLoco motif, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
G-protein signaling modulator 2 (AGS3-like, C. elegans),SMART[760000020$SM00028:TPR, 760000342$SM00390:GoLoco]
G-protein signaling modulator 2 (AGS3-like, C. elegans),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat, 790001537$tpr repeat]
G-protein signaling modulator 2 (AGS3-like, C. elegans),UP_SEQ_FEATURE[850020318$chain:G-protein-signaling modulator 2, 850104071$domain:GoLoco 1, 850104072$domain:GoLoco 2, 850104073$domain:GoLoco 3, 850104074$domain:GoLoco 4, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117294$sequence conflict]
Hermansky-Pudlak syndrome 1,OMIM_DISEASE[520002302$Hermansky-Pudlak syndrome 1]
Hermansky-Pudlak syndrome 1,PIR_SUPERFAMILY[630028443$PIRSF036954:HPS1]
Hermansky-Pudlak syndrome 1,SP_PIR_KEYWORDS[790000035$Albinism, 790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000676$Hermansky-Pudlak syndrome, 790001212$polymorphism, 790001304$repeat, 790001377$sensory transduction, 790001622$vision]
Hermansky-Pudlak syndrome 1,UP_SEQ_FEATURE[850023530$chain:Hermansky-Pudlak syndrome 1 protein, 850102572$compositionally biased region:Poly-Glu, 850117290$repeat:[DE]-X(4)-L-L 1, 850117291$repeat:[DE]-X(4)-L-L 2, 850117292$repeat:[DE]-X(4)-L-L 3, 850117293$repeat:[DE]-X(4)-L-L 4, 850117294$sequence conflict, 850117295$sequence variant, 850117575$short sequence motif:Melanosome targeting signal, 850118574$splice variant]
OTU domain, ubiquitin aldehyde binding 1,INTERPRO[450002899$IPR003323:Ovarian tumour, otubain, 450014937$IPR016615:Ubiquitin thioesterase Otubain, 450017638$IPR019400:Peptidase C65, otubain]
OTU domain, ubiquitin aldehyde binding 1,PIR_SUPERFAMILY[630011258$PIRSF013503:ubiquitin thioesterase Otubain, 630011259$PIRSF013503:Ubiquitin_thioesterase_Otubain]
OTU domain, ubiquitin aldehyde binding 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000763$immune response, 790001162$phosphoprotein, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway]
OTU domain, ubiquitin aldehyde binding 1,UP_SEQ_FEATURE[850068041$chain:Ubiquitin thioesterase OTUB1, 850104870$domain:OTU, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118536$site:Required for proximal ubiquitin-binding, 850118574$splice variant, 850118575$strand, 850118624$turn]
RAD9 homolog A (S. pombe),BIOCARTA[30000029$h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility]
RAD9 homolog A (S. pombe),INTERPRO[450006636$IPR007268:Rad9, 450014874$IPR016552:Cell cycle checkpoint, RAD9]
RAD9 homolog A (S. pombe),PIR_SUPERFAMILY[630008452$PIRSF009303:Cell_cycle_RAD9]
RAD9 homolog A (S. pombe),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000452$DNA damage, 790000459$dna repair, 790000523$exonuclease, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
RAD9 homolog A (S. pombe),UP_SEQ_FEATURE[850010253$chain:Cell cycle checkpoint control protein RAD9A, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850114090$region of interest:Possesses 3'-5' exonuclease activity, 850114743$region of interest:Sufficient for interaction with ABL1, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
RAN guanine nucleotide release factor,INTERPRO[450007038$IPR007681:Ran-interacting Mog1 protein, 450014485$IPR016123:Mog1/PsbP, alpha/beta/alpha sandwich]
RAN guanine nucleotide release factor,PIR_SUPERFAMILY[630021695$PIRSF028828:nuclear import protein MOG1]
RAN guanine nucleotide release factor,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000641$guanine-nucleotide releasing factor, 790001065$nucleus, 790001266$protein transport, 790001558$transport]
RAN guanine nucleotide release factor,UP_SEQ_FEATURE[850056614$chain:Ran guanine nucleotide release factor, 850117294$sequence conflict, 850118574$splice variant]
RUN and FYVE domain containing 3,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
RUN and FYVE domain containing 3,INTERPRO[450003532$IPR004012:RUN]
RUN and FYVE domain containing 3,SMART[760000527$SM00593:RUN]
RUN and FYVE domain containing 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001016$neurogenesis, 790001162$phosphoprotein]
RUN and FYVE domain containing 3,UP_SEQ_FEATURE[850047544$chain:Protein RUFY3, 850105223$domain:RUN, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
Rho GTPase activating protein 21,INTERPRO[450000169$IPR000198:RhoGAP, 450001316$IPR001478:PDZ/DHR/GLGF, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
Rho GTPase activating protein 21,SMART[760000200$SM00228:PDZ, 760000205$SM00233:PH, 760000293$SM00324:RhoGAP]
Rho GTPase activating protein 21,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000356$complete proteome, 790000407$cytoplasm, 790000408$cytoplasmic vesicle, 790000410$cytoskeleton, 790000624$golgi apparatus, 790000640$GTPase activation, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
Rho GTPase activating protein 21,UP_SEQ_FEATURE[850057536$chain:Rho GTPase-activating protein 21, 850104918$domain:PDZ, 850104979$domain:PH, 850105183$domain:Rho-GAP, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112088$region of interest:Interaction with ARF1 and ARF6, 850112230$region of interest:Interaction with CTNNA1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
SEC14-like 2 (S. cerevisiae),INTERPRO[450000939$IPR001071:Cellular retinaldehyde binding/alpha-tocopherol transport, 450001103$IPR001251:Cellular retinaldehyde-binding/triple function, C-terminal, 450007565$IPR008273:Cellular retinaldehyde-binding/triple function, N-terminal, 450008192$IPR009038:GOLD]
SEC14-like 2 (S. cerevisiae),SMART[760000458$SM00516:SEC14]
SEC14-like 2 (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000356$complete proteome, 790000407$cytoplasm, 790000876$lipid-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001558$transport]
SEC14-like 2 (S. cerevisiae),UP_SEQ_FEATURE[850059082$chain:SEC14-like protein 2, 850103410$domain:CRAL-TRIO, 850104069$domain:GOLD, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
SET domain containing (lysine methyltransferase) 8,INTERPRO[450001068$IPR001214:SET, 450015178$IPR016858:Histone H4-K20 methyltransferase]
SET domain containing (lysine methyltransferase) 8,KEGG_PATHWAY[470038751$hsa00310:Lysine degradation]
SET domain containing (lysine methyltransferase) 8,PIR_SUPERFAMILY[630020983$PIRSF027717:histone H4-K20 methyltransferase, 630020984$PIRSF027717:Histone_H4-K20_mtfrase]
SET domain containing (lysine methyltransferase) 8,SMART[760000286$SM00317:SET]
SET domain containing (lysine methyltransferase) 8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000311$chromatin regulator, 790000315$chromosomal protein, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000954$methyltransferase, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001348$s-adenosyl-l-methionine, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase]
SET domain containing (lysine methyltransferase) 8,UP_SEQ_FEATURE[850000532$binding site:S-adenosyl-L-methionine, 850024166$chain:Histone-lysine N-methyltransferase SETD8, 850102378$compositionally biased region:Ala-rich, 850102566$compositionally biased region:Poly-Arg, 850105340$domain:SET, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850114570$region of interest:S-adenosyl-L-methionine binding, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
SH2 domain containing 7,INTERPRO[450000852$IPR000980:SH2 motif]
SH2 domain containing 7,SMART[760000224$SM00252:SH2]
SH2 domain containing 7,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001397$SH2 domain]
SH2 domain containing 7,UP_SEQ_FEATURE[850060518$chain:SH2 domain-containing protein 7, 850105346$domain:SH2, 850117295$sequence variant]
SON DNA binding protein,INTERPRO[450000396$IPR000467:D111/G-patch, 450001016$IPR001159:Double-stranded RNA binding, 450013172$IPR014720:Double-stranded RNA-binding-like]
SON DNA binding protein,SMART[760000326$SM00358:DSRM, 760000389$SM00443:G_patch]
SON DNA binding protein,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
SON DNA binding protein,UP_SEQ_FEATURE[850047769$chain:Protein SON, 850103545$domain:DRBM, 850104022$domain:G-patch, 850106258$modified residue, 850109795$region of interest:11 X 7 AA tandem repeats of [DR]-P-Y-R- [LI][AG][QHP], 850109870$region of interest:14 X 6 AA repeats of [ED]-R-S-M-M-S, 850109918$region of interest:17 X 10 AA tandem repeats of L-A-[ST]- [NSG]-[TS]-MDSQM, 850109990$region of interest:2 X 19 AA repeats of P-S-R-R-R-R-S-R-S-V- V-R-R-R-S-F-S-I-S, 850110193$region of interest:3 X 11 AA tandem repats of P-P-L-P-P-E-E- P-P-[TME]-[MTG], 850110291$region of interest:3 X tandem repeats of [ST]-P-[VLI]-R- [RL]-[RK]-[RF]-S-R, 850110418$region of interest:4 X 8 AA tandem repeats of V-L-E-SS- [AVT]-VT, 850110672$region of interest:7 X 7 AA repeats of P-S-R-R-S-R-[TS], 850115075$repeat:1-1, 850115076$repeat:1-10, 850115078$repeat:1-11, 850115080$repeat:1-12, 850115082$repeat:1-13, 850115083$repeat:1-14, 850115091$repeat:1-2, 850115103$repeat:1-3, 850115113$repeat:1-4, 850115116$repeat:1-5, 850115119$repeat:1-6, 850115122$repeat:1-7, 850115124$repeat:1-8, 850115126$repeat:1-9, 850115274$repeat:2-1, 850115291$repeat:2-2, 850115306$repeat:2-3, 850115315$repeat:2-4, 850115317$repeat:2-5, 850115320$repeat:2-6, 850115322$repeat:2-7, 850115418$repeat:3-1, 850115430$repeat:3-2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2,COG_ONTOLOGY[90000042$Chromatin structure and dynamics]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2,INTERPRO[450002745$IPR003121:SWIB/MDM2 domain]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2,PIR_SUPERFAMILY[630029698$PIRSF038112:SWI/SNF-related matrix-associated actin-dependent regulator]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2,UP_SEQ_FEATURE[850063127$chain:SWI/SNF-related matrix-associated actin- dependent regulator of chromatin subfamily D member 2, 850105452$domain:SWIB, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
Sp4 transcription factor,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
Sp4 transcription factor,PIR_SUPERFAMILY[630029160$PIRSF037570:transcription factor, Sp1/Sp2/Sp3/Sp4 types, 630030979$PIRSF500823:transcription factor Sp4]
Sp4 transcription factor,SMART[760000323$SM00355:ZnF_C2H2]
Sp4 transcription factor,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
Sp4 transcription factor,UP_SEQ_FEATURE[850065343$chain:Transcription factor Sp4, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3]
TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa,COG_ONTOLOGY[90000007$Amino acid transport and metabolism]
TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa,INTERPRO[450013233$IPR014782:Peptidase M1, membrane alanine aminopeptidase, N-terminal]
TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa,KEGG_PATHWAY[470038816$hsa03022:Basal transcription factors]
TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa,SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa,UP_SEQ_FEATURE[850065454$chain:Transcription initiation factor TFIID subunit 2, 850102540$compositionally biased region:His-rich, 850102554$compositionally biased region:Lys-rich, 850102577$compositionally biased region:Poly-Lys, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
TNF receptor-associated factor 7,INTERPRO[450001138$IPR001293:Zinc finger, TRAF-type, 450001490$IPR001680:WD40 repeat, 450001628$IPR001841:Zinc finger, RING-type, 450014355$IPR015943:WD40/YVTN repeat-like, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450016294$IPR017986:WD40 repeat, region, 450017227$IPR018957:Zinc finger, C3HC4 RING-type, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
TNF receptor-associated factor 7,SMART[760000158$SM00184:RING, 760000289$SM00320:WD40]
TNF receptor-associated factor 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000859$ligase, 790000937$metal-binding, 790001162$phosphoprotein, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001638$wd repeat, 790001648$zinc, 790001651$zinc-finger]
TNF receptor-associated factor 7,UP_SEQ_FEATURE[850016762$chain:E3 ubiquitin-protein ligase TRAF7, 850106258$modified residue, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850118574$splice variant, 850118911$zinc finger region:RING-type, 850118936$zinc finger region:TRAF-type]
actin-like 8,INTERPRO[450003522$IPR004000:Actin/actin-like]
actin-like 8,PIR_SUPERFAMILY[630002457$PIRSF002337:Actin]
actin-like 8,SMART[760000240$SM00268:ACTIN]
actin-like 8,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism]
actin-like 8,UP_SEQ_FEATURE[850003608$chain:Actin-like protein 8, 850117295$sequence variant]
adaptor-related protein complex 1, mu 2 subunit,INTERPRO[450001237$IPR001392:Clathrin adaptor, mu subunit, 450008176$IPR008968:Clathrin adaptor, mu subunit, C-terminal, 450016525$IPR018240:Clathrin adaptor, mu subunit, conserved site]
adaptor-related protein complex 1, mu 2 subunit,KEGG_PATHWAY[470038840$hsa04142:Lysosome]
adaptor-related protein complex 1, mu 2 subunit,PIR_SUPERFAMILY[630005930$PIRSF005992:adaptor protein complex, mu subunit, 630005931$PIRSF005992:Clathrin_mu]
adaptor-related protein complex 1, mu 2 subunit,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
adaptor-related protein complex 1, mu 2 subunit,UP_SEQ_FEATURE[850005704$chain:AP-1 complex subunit mu-2, 850104767$domain:MHD, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
aldehyde dehydrogenase 8 family, member A1,INTERPRO[450014029$IPR015590:Aldehyde dehydrogenase, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450014510$IPR016162:Aldehyde dehydrogenase, N-terminal]
aldehyde dehydrogenase 8 family, member A1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001006$nad, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism]
aldehyde dehydrogenase 8 family, member A1,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000114$active site:Proton acceptor, 850004339$chain:Aldehyde dehydrogenase family 8 member A1, 850106258$modified residue, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850117295$sequence variant, 850118573$site:Transition state stabilizer, 850118574$splice variant]
armadillo repeat containing 10,INTERPRO[450006311$IPR006911:Protein of unknown function DUF634, 450010814$IPR011989:Armadillo-like helical]
armadillo repeat containing 10,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000635$growth regulation, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
armadillo repeat containing 10,UP_SEQ_FEATURE[850006117$chain:Armadillo repeat-containing protein 10, 850106258$modified residue, 850115673$repeat:ARM, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
bicaudal D homolog 1 (Drosophila),INTERPRO[450016751$IPR018477:Bicaudal-D protein, microtubule-associated]
bicaudal D homolog 1 (Drosophila),OMIM_DISEASE[520001996$Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis]
bicaudal D homolog 1 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790001162$phosphoprotein]
bicaudal D homolog 1 (Drosophila),UP_SEQ_FEATURE[850045210$chain:Protein bicaudal D homolog 1, 850113113$region of interest:Interacts with RAB6A, 850117294$sequence conflict, 850118574$splice variant]
bone morphogenetic protein 8a,INTERPRO[450000974$IPR001111:Transforming growth factor beta (TGFb), N-terminal, 450001626$IPR001839:Transforming growth factor beta, 450002138$IPR002405:Inhibin, alpha subunit, 450014053$IPR015615:Transforming growth factor-beta-related, 450016259$IPR017948:Transforming growth factor beta, conserved site]
bone morphogenetic protein 8a,KEGG_PATHWAY[470038849$hsa04340:Hedgehog signaling pathway, 470038850$hsa04350:TGF-beta signaling pathway]
bone morphogenetic protein 8a,SMART[760000177$SM00204:TGFB]
bone morphogenetic protein 8a,SP_PIR_KEYWORDS[790000307$Chondrogenesis, 790000356$complete proteome, 790000402$cytokine, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000632$growth factor, 790001083$osteogenesis, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
bone morphogenetic protein 8a,UP_SEQ_FEATURE[850008229$chain:Bone morphogenetic protein 8A, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide]
bone morphogenetic protein 8b,INTERPRO[450000974$IPR001111:Transforming growth factor beta (TGFb), N-terminal, 450001626$IPR001839:Transforming growth factor beta, 450002138$IPR002405:Inhibin, alpha subunit, 450014053$IPR015615:Transforming growth factor-beta-related, 450016259$IPR017948:Transforming growth factor beta, conserved site]
bone morphogenetic protein 8b,KEGG_PATHWAY[470038849$hsa04340:Hedgehog signaling pathway, 470038850$hsa04350:TGF-beta signaling pathway]
bone morphogenetic protein 8b,SMART[760000177$SM00204:TGFB]
bone morphogenetic protein 8b,SP_PIR_KEYWORDS[790000307$Chondrogenesis, 790000356$complete proteome, 790000402$cytokine, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000632$growth factor, 790001083$osteogenesis, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
bone morphogenetic protein 8b,UP_SEQ_FEATURE[850008230$chain:Bone morphogenetic protein 8B, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
calmodulin binding transcription activator 1,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450001870$IPR002110:Ankyrin, 450002569$IPR002909:Cell surface receptor IPT/TIG, 450005011$IPR005559:CG-1]
calmodulin binding transcription activator 1,SMART[760000009$SM00015:IQ, 760000220$SM00248:ANK, 760000375$SM00429:IPT]
calmodulin binding transcription activator 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
calmodulin binding transcription activator 1,UP_SEQ_FEATURE[850009135$chain:Calmodulin-binding transcription activator 1, 850102573$compositionally biased region:Poly-Gly, 850102585$compositionally biased region:Poly-Val, 850102903$DNA-binding region:CG-1, 850104420$domain:IPT/TIG, 850104440$domain:IQ 1, 850104451$domain:IQ 2, 850104462$domain:IQ 3, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand]
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7,INTERPRO[450000753$IPR000863:Sulfotransferase, 450014790$IPR016469:Carbohydrate sulfotransferase]
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7,PIR_SUPERFAMILY[630005810$PIRSF005883:carbohydrate sulfotransferase, 630005811$PIRSF005883:Carbohydrate_sulfotransferase]
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7,SP_PIR_KEYWORDS[790000232$carbohydrate metabolism, 790000356$complete proteome, 790000615$glycolysis, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001409$Signal-anchor, 790001460$sulfate transport, 790001464$sulfotransferase, 790001547$transferase, 790001555$transmembrane, 790001556$transmembrane protein]
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7,UP_SEQ_FEATURE[850009416$chain:Carbohydrate sulfotransferase 7, 850105770$glycosylation site:N-linked (GlcNAc...), 850106312$nucleotide phosphate-binding region:PAPS, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
catenin, beta interacting protein 1,INTERPRO[450008532$IPR009428:Beta-catenin-interacting ICAT]
catenin, beta interacting protein 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway]
catenin, beta interacting protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001642$wnt signaling pathway]
catenin, beta interacting protein 1,UP_SEQ_FEATURE[850007601$chain:Beta-catenin-interacting protein 1, 850105852$helix]
chemokine (C-C motif) ligand 13,BBID[10000012$109.Chemokine_families]
chemokine (C-C motif) ligand 13,INTERPRO[450000719$IPR000827:Small chemokine, C-C group, conserved site, 450001604$IPR001811:Small chemokine, interleukin-8-like]
chemokine (C-C motif) ligand 13,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway, 470038863$hsa04621:NOD-like receptor signaling pathway]
chemokine (C-C motif) ligand 13,PIR_SUPERFAMILY[630002087$PIRSF001950:small inducible chemokine, C/CC types, 630030769$PIRSF500572:small inducible cytokine, A2 type]
chemokine (C-C motif) ligand 13,SMART[760000172$SM00199:SCY]
chemokine (C-C motif) ligand 13,SP_PIR_KEYWORDS[790000002$3d-structure, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000775$inflammatory response, 790001212$polymorphism, 790001291$Pyrrolidone carboxylic acid, 790001363$Secreted, 790001405$signal]
chemokine (C-C motif) ligand 13,UP_SEQ_FEATURE[850008601$chain:C-C motif chemokine 13, long chain, 850008602$chain:C-C motif chemokine 13, medium chain, 850008603$chain:C-C motif chemokine 13, short chain, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand]
chemokine (C-C motif) ligand 8,BBID[10000012$109.Chemokine_families]
chemokine (C-C motif) ligand 8,INTERPRO[450000719$IPR000827:Small chemokine, C-C group, conserved site, 450001604$IPR001811:Small chemokine, interleukin-8-like]
chemokine (C-C motif) ligand 8,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway, 470038863$hsa04621:NOD-like receptor signaling pathway]
chemokine (C-C motif) ligand 8,PIR_SUPERFAMILY[630002087$PIRSF001950:small inducible chemokine, C/CC types, 630030769$PIRSF500572:small inducible cytokine, A2 type]
chemokine (C-C motif) ligand 8,SMART[760000172$SM00199:SCY]
chemokine (C-C motif) ligand 8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000669$heparin-binding, 790000775$inflammatory response, 790001212$polymorphism, 790001291$Pyrrolidone carboxylic acid, 790001363$Secreted, 790001405$signal]
chemokine (C-C motif) ligand 8,UP_SEQ_FEATURE[850008630$chain:C-C motif chemokine 8, 850030715$chain:MCP-2(6-76), 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
chemokine (C-X-C motif) receptor 5,BBID[10000043$16.Chemokines-rec-T-cells]
chemokine (C-X-C motif) receptor 5,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000922$IPR001053:C-X-C chemokine receptor, type 5, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
chemokine (C-X-C motif) receptor 5,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway]
chemokine (C-X-C motif) receptor 5,PIR_SUPERFAMILY[630030051$PIRSF038545:chemokine receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
chemokine (C-X-C motif) receptor 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000153$b-cell activation, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
chemokine (C-X-C motif) receptor 5,UP_SEQ_FEATURE[850008769$chain:C-X-C chemokine receptor type 5, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromodomain helicase DNA binding protein 8,INTERPRO[450000283$IPR000330:SNF2-related, 450000831$IPR000953:Chromo domain, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450002185$IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site, 450005996$IPR006576:BRK domain, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
chromodomain helicase DNA binding protein 8,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway]
chromodomain helicase DNA binding protein 8,SMART[760000268$SM00298:CHROMO, 760000432$SM00487:DEXDc, 760000434$SM00490:HELICc, 760000526$SM00592:BRK]
chromodomain helicase DNA binding protein 8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000138$atp-binding, 790000311$chromatin regulator, 790000356$complete proteome, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790000811$isopeptide bond, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001642$wnt signaling pathway]
chromodomain helicase DNA binding protein 8,UP_SEQ_FEATURE[850011389$chain:Chromodomain-helicase-DNA-binding protein 8, 850102458$compositionally biased region:Asp-rich, 850102485$compositionally biased region:Gln-rich, 850102540$compositionally biased region:His-rich, 850102597$compositionally biased region:Ser-rich, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850103362$domain:Chromo 1, 850103363$domain:Chromo 2, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117387$short sequence motif:DEAH box, 850118574$splice variant, 850118575$strand, 850118624$turn]
chromosome 10 open reading frame 119,INTERPRO[450017386$IPR019140:Protein of unknown function DUF2044, membrane]
chromosome 10 open reading frame 119,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 10 open reading frame 119,UP_SEQ_FEATURE[850097744$chain:UPF0557 protein C10orf119, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
collagen, type VI, alpha 3,INTERPRO[450001802$IPR002035:von Willebrand factor, type A, 450001971$IPR002223:Proteinase inhibitor I2, Kunitz metazoa, 450003484$IPR003961:Fibronectin, type III, 450007490$IPR008160:Collagen triple helix repeat, 450008173$IPR008957:Fibronectin, type III-like fold]
collagen, type VI, alpha 3,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038854$hsa04512:ECM-receptor interaction]
collagen, type VI, alpha 3,OMIM_DISEASE[520000561$Bethlem myopathy, 520004976$Ullrich congenital muscular dystrophy]
collagen, type VI, alpha 3,PIR_SUPERFAMILY[630002388$PIRSF002259:collagen VI]
collagen, type VI, alpha 3,SMART[760000051$SM00060:FN3, 760000113$SM00131:KU, 760000296$SM00327:VWA]
collagen, type VI, alpha 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000189$blocked amino end, 790000256$cell adhesion, 790000257$cell binding, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001253$protease inhibitor, 790001289$pyroglutamic acid, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001363$Secreted, 790001385$Serine protease inhibitor, 790001405$signal, 790001565$trimer, 790001568$triple helix]
collagen, type VI, alpha 3,UP_SEQ_FEATURE[850012213$chain:Collagen alpha-3(VI) chain, 850102378$compositionally biased region:Ala-rich, 850102605$compositionally biased region:Thr-rich, 850102883$disulfide bond, 850103140$domain:BPTI/Kunitz inhibitor, 850103390$domain:Collagen-like 1, 850103399$domain:Collagen-like 2, 850103400$domain:Collagen-like 3, 850103401$domain:Collagen-like 4, 850103402$domain:Collagen-like 5, 850103799$domain:Fibronectin type-III, 850105628$domain:VWFA 1, 850105629$domain:VWFA 10, 850105630$domain:VWFA 11, 850105631$domain:VWFA 12, 850105633$domain:VWFA 2, 850105634$domain:VWFA 3, 850105637$domain:VWFA 4, 850105638$domain:VWFA 5, 850105639$domain:VWFA 6, 850105640$domain:VWFA 7, 850105641$domain:VWFA 8, 850105642$domain:VWFA 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850105818$glycosylation site:O-linked (Gal...), 850105852$helix, 850106258$modified residue, 850113761$region of interest:Nonhelical region, 850114937$region of interest:Triple-helical region, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116313$repeat:LRR 14, 850116314$repeat:LRR 15, 850116315$repeat:LRR 16, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide, 850118488$site:Reactive bond, 850118574$splice variant, 850118575$strand, 850118624$turn]
cytoplasmic polyadenylation element binding protein 3,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
cytoplasmic polyadenylation element binding protein 3,SMART[760000328$SM00360:RRM]
cytoplasmic polyadenylation element binding protein 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
cytoplasmic polyadenylation element binding protein 3,UP_SEQ_FEATURE[850014052$chain:Cytoplasmic polyadenylation element- binding protein 3, 850102378$compositionally biased region:Ala-rich, 850102485$compositionally biased region:Gln-rich, 850102586$compositionally biased region:Pro-rich, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
electron-transfer-flavoprotein, alpha polypeptide,COG_ONTOLOGY[90000064$Energy production and conversion]
electron-transfer-flavoprotein, alpha polypeptide,INTERPRO[450001152$IPR001308:Electron transfer flavoprotein, alpha subunit, 450013180$IPR014729:Rossmann-like alpha/beta/alpha sandwich fold, 450013181$IPR014730:Electron transfer flavoprotein, alpha/beta-subunit, N-terminal, 450013182$IPR014731:Electron transfer flavoprotein, alpha subunit, C-terminal, 450016493$IPR018206:Electron transfer flavoprotein, alpha subunit, C-terminal, conserved site]
electron-transfer-flavoprotein, alpha polypeptide,OMIM_DISEASE[520002133$Glutaricaciduria, type IIA]
electron-transfer-flavoprotein, alpha polypeptide,PIR_SUPERFAMILY[630000101$PIRSF000089:Electra_flavoP_a, 630000102$PIRSF000089:electron transfer flavoprotein, alpha subunit]
electron-transfer-flavoprotein, alpha polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000489$electron transport, 790000537$FAD, 790000559$Flavoprotein, 790000601$Glutaricaciduria, 790000969$mitochondrion, 790001162$phosphoprotein, 790001212$polymorphism, 790001550$transit peptide, 790001558$transport]
electron-transfer-flavoprotein, alpha polypeptide,UP_SEQ_FEATURE[850017044$chain:Electron transfer flavoprotein subunit alpha, mitochondrial, 850105852$helix, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
enolase 2 (gamma, neuronal),INTERPRO[450000822$IPR000941:Enolase]
enolase 2 (gamma, neuronal),KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038814$hsa03018:RNA degradation]
enolase 2 (gamma, neuronal),PIR_SUPERFAMILY[630001557$PIRSF001400:Enolase]
enolase 2 (gamma, neuronal),SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000615$glycolysis, 790000891$lyase, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism]
enolase 2 (gamma, neuronal),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000131$active site:Proton donor, 850000555$binding site:Substrate, 850020529$chain:Gamma-enolase, 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850114716$region of interest:Substrate binding, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
epithelial membrane protein 2,INTERPRO[450003458$IPR003933:Epithelial membrane protein EMP-2, 450003550$IPR004031:PMP-22/EMP/MP20/Claudin, 450003551$IPR004032:PMP-22/EMP/MP20]
epithelial membrane protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
epithelial membrane protein 2,UP_SEQ_FEATURE[850017705$chain:Epithelial membrane protein 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118623$transmembrane region]
family with sequence similarity 175, member B,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
family with sequence similarity 175, member B,UP_SEQ_FEATURE[850008400$chain:BRISC complex subunit Abro1, 850106258$modified residue, 850113479$region of interest:MPN-like, 850117294$sequence conflict]
glial fibrillary acidic protein,BIOCARTA[30000239$h_prionPathway:Prion Pathway]
glial fibrillary acidic protein,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450006225$IPR006821:Intermediate filament, DNA-binding region, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
glial fibrillary acidic protein,OMIM_DISEASE[520000214$Alexander disease]
glial fibrillary acidic protein,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
glial fibrillary acidic protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000788$Intermediate filament, 790001162$phosphoprotein, 790001212$polymorphism]
glial fibrillary acidic protein,UP_SEQ_FEATURE[850021232$chain:Glial fibrillary acidic protein, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111277$region of interest:Coil 2A, 850111278$region of interest:Coil 2B, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850113286$region of interest:Linker 2, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2,INTERPRO[450000892$IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit, 450001254$IPR001408:G-protein alpha subunit, group I]
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2,OMIM_DISEASE[520000106$Achromatopsia-4]
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2,PIR_SUPERFAMILY[630002519$PIRSF002400:GTP-binding regulatory protein Gs alpha chain]
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2,SP_PIR_KEYWORDS[790000028$ADP-ribosylation, 790000356$complete proteome, 790000637$GTP binding, 790000639$gtp-binding, 790000687$heterotrimer, 790000881$lipoprotein, 790001004$myristate, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001212$polymorphism, 790001377$sensory transduction, 790001407$signal transduction, 790001546$transducer, 790001622$vision]
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2,UP_SEQ_FEATURE[850022741$chain:Guanine nucleotide-binding protein G(t) subunit alpha-2, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant]
heat shock 70kDa protein 14,INTERPRO[450000896$IPR001023:Heat shock protein Hsp70, 450011768$IPR013126:Heat shock protein 70, 450016471$IPR018181:Heat shock protein 70, conserved site]
heat shock 70kDa protein 14,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790001063$nucleotide-binding, 790001212$polymorphism, 790001450$stress response]
heat shock 70kDa protein 14,UP_SEQ_FEATURE[850023042$chain:Heat shock 70 kDa protein 14, 850117294$sequence conflict, 850117295$sequence variant]
iron-sulfur cluster scaffold homolog (E. coli),INTERPRO[450002538$IPR002871:NIF system FeS cluster assembly, NifU, N-terminal, 450010234$IPR011339:ISC system FeS cluster assembly, IscU scaffold]
iron-sulfur cluster scaffold homolog (E. coli),OMIM_DISEASE[520003486$Myopathy with exercise intolerance, Swedish type]
iron-sulfur cluster scaffold homolog (E. coli),PIR_SUPERFAMILY[630000436$PIRSF000374:iron-sulfur cluster assembly protein, IscU type]
iron-sulfur cluster scaffold homolog (E. coli),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000802$iron, 790000937$metal-binding, 790000969$mitochondrion, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001550$transit peptide]
iron-sulfur cluster scaffold homolog (E. coli),UP_SEQ_FEATURE[850026800$chain:Iron-sulfur cluster assembly enzyme ISCU, mitochondrial, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
karyopherin (importin) beta 1,BIOCARTA[30000208$h_npcPathway:Mechanism of Protein Import into the Nucleus, 30000251$h_ranMSpathway:Role of Ran in mitotic spindle regulation]
karyopherin (importin) beta 1,COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
karyopherin (importin) beta 1,INTERPRO[450000194$IPR000225:Armadillo, 450000307$IPR000357:HEAT, 450001329$IPR001494:Importin-beta, N-terminal, 450010814$IPR011989:Armadillo-like helical]
karyopherin (importin) beta 1,SMART[760000159$SM00185:ARM]
karyopherin (importin) beta 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000811$isopeptide bond, 790001065$nucleus, 790001162$phosphoprotein, 790001266$protein transport, 790001304$repeat, 790001558$transport, 790001592$ubl conjugation]
karyopherin (importin) beta 1,UP_SEQ_FEATURE[850025659$chain:Importin subunit beta-1, 850102568$compositionally biased region:Poly-Asp, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850104418$domain:Importin N-terminal, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111945$region of interest:IAB-binding, 850114174$region of interest:Ran-GTP binding, 850116140$repeat:HEAT 1, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850116165$repeat:HEAT 6, 850116166$repeat:HEAT 7, 850116167$repeat:HEAT 8, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
keratin 18; keratin 18 pseudogene 26; keratin 18 pseudogene 19,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002605$IPR002957:Keratin, type I, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 18; keratin 18 pseudogene 26; keratin 18 pseudogene 19,KEGG_PATHWAY[470038898$hsa05130:Pathogenic Escherichia coli infection]
keratin 18; keratin 18 pseudogene 26; keratin 18 pseudogene 19,OMIM_DISEASE[520001049$Cirrhosis, cryptogenic, 520001050$Cirrhosis, noncryptogenic, susceptibility to]
keratin 18; keratin 18 pseudogene 26; keratin 18 pseudogene 19,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 18; keratin 18 pseudogene 26; keratin 18 pseudogene 19,SP_PIR_KEYWORDS[790000012$acetylation, 790000258$cell cycle, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000616$glycoprotein, 790000733$host-virus interaction, 790000788$Intermediate filament, 790000821$keratin, 790001162$phosphoprotein, 790001212$polymorphism]
keratin 18; keratin 18 pseudogene 26; keratin 18 pseudogene 19,UP_SEQ_FEATURE[850027178$chain:Keratin, type I cytoskeletal 18, 850105829$glycosylation site:O-linked (GlcNAc), 850106258$modified residue, 850106259$mutagenesis site, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850112261$region of interest:Interaction with DNAJB6, 850112967$region of interest:Interaction with TRADD, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850113626$region of interest:Necessary for interaction with PNN, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118026$site:Cleavage; by caspase-3, caspase-6 or caspase-7, 850118563$site:Stutter]
keratin associated protein 10-7,INTERPRO[450002214$IPR002494:Keratin, high sulphur B2 protein]
keratin associated protein 10-7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000821$keratin, 790001212$polymorphism, 790001304$repeat]
keratin associated protein 10-7,UP_SEQ_FEATURE[850027243$chain:Keratin-associated protein 10-7, 850110309$region of interest:30 X 5 AA repeats of C-C-X(3), 850115074$repeat:1, 850115131$repeat:10, 850115147$repeat:11, 850115162$repeat:12, 850115175$repeat:13, 850115188$repeat:14, 850115201$repeat:15, 850115216$repeat:16, 850115231$repeat:17, 850115245$repeat:18, 850115257$repeat:19, 850115273$repeat:2, 850115331$repeat:20, 850115343$repeat:21, 850115355$repeat:22, 850115367$repeat:23, 850115380$repeat:24, 850115392$repeat:25, 850115404$repeat:26, 850115408$repeat:27, 850115410$repeat:28, 850115412$repeat:29, 850115417$repeat:3, 850115444$repeat:30, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ligand dependent nuclear receptor corepressor,INTERPRO[450007237$IPR007889:Helix-turn-helix, Psq, 450010388$IPR011526:Helix-turn-helix, Psq-like]
ligand dependent nuclear receptor corepressor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
ligand dependent nuclear receptor corepressor,UP_SEQ_FEATURE[850028553$chain:Ligand-dependent corepressor, 850102916$DNA-binding region:H-T-H motif, 850104179$domain:HTH psq-type, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117504$short sequence motif:Interaction with nuclear receptors, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118624$turn]
mitochondrial ribosomal protein S33,INTERPRO[450011856$IPR013219:Ribosomal protein S27/S33, mitochondrial]
mitochondrial ribosomal protein S33,PIR_SUPERFAMILY[630007501$PIRSF007780:mitochondrial ribosomal protein, S33/fungal Rsm27 types]
mitochondrial ribosomal protein S33,SP_PIR_KEYWORDS[790000356$complete proteome, 790000969$mitochondrion, 790001325$ribonucleoprotein, 790001329$ribosomal protein]
mitochondrial ribosomal protein S33,UP_SEQ_FEATURE[850001330$chain:28S ribosomal protein S33, mitochondrial]
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor),BIOCARTA[30000124$h_gcrPathway:Corticosteroids and cardioprotection, 30000142$h_hSWI-SNFpathway:Chromatin Remodeling by hSWI/SNF ATP-dependent Complexes, 30000210$h_nthiPathway:NFkB activation by Nontypeable Hemophilus influenzae, 30000311$h_vobesityPathway:Visceral Fat Deposits and the Metabolic Syndrome]
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor),INTERPRO[450000459$IPR000536:Nuclear hormone receptor, ligand-binding, core, 450001255$IPR001409:Glucocorticoid receptor, 450001442$IPR001628:Zinc finger, nuclear hormone receptor-type, 450001527$IPR001723:Steroid hormone receptor, 450008168$IPR008946:Nuclear hormone receptor, ligand-binding, 450011732$IPR013088:Zinc finger, NHR/GATA-type]
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor),KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor),OMIM_DISEASE[520001244$Cortisol resistance]
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor),PIR_SUPERFAMILY[630002647$PIRSF002529:glucocorticoid receptor]
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor),SMART[760000350$SM00399:ZnF_C4, 760000376$SM00430:HOLI]
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor),SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000449$DNA binding, 790000466$dna-binding, 790000811$isopeptide bond, 790000876$lipid-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001273$pseudohermaphroditism, 790001301$receptor, 790001441$steroid hormone receptor, 790001443$steroid-binding, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor),UP_SEQ_FEATURE[850021370$chain:Glucocorticoid receptor, 850102515$compositionally biased region:Glu/Pro/Ser/Thr-rich (PEST region), 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850102946$DNA-binding region:Nuclear receptor, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111880$region of interest:Hinge, 850113461$region of interest:Modulating, 850114699$region of interest:Steroid-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118866$zinc finger region:NR C4-type]
pleckstrin homology domain containing, family A member 7,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP, 450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
pleckstrin homology domain containing, family A member 7,SMART[760000205$SM00233:PH, 760000401$SM00456:WW]
pleckstrin homology domain containing, family A member 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
pleckstrin homology domain containing, family A member 7,UP_SEQ_FEATURE[850039554$chain:Pleckstrin homology domain-containing family A member 7, 850102586$compositionally biased region:Pro-rich, 850104979$domain:PH, 850105732$domain:WW 1, 850105733$domain:WW 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
potassium channel tetramerisation domain containing 21,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450002755$IPR003131:Potassium channel, voltage dependent, Kv,  tetramerisation, 450010229$IPR011333:BTB/POZ fold]
potassium channel tetramerisation domain containing 21,SMART[760000197$SM00225:BTB]
potassium channel tetramerisation domain containing 21,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome]
potassium channel tetramerisation domain containing 21,UP_SEQ_FEATURE[850008484$chain:BTB/POZ domain-containing protein KCTD21, 850102581$compositionally biased region:Poly-Ser, 850103177$domain:BTB]
potassium channel, subfamily K, member 7,INTERPRO[450002860$IPR003280:Potassium channel, two pore-domain, 450004866$IPR005408:Potassium channel, two pore-domain, TWIK, 450011743$IPR013099:Ion transport 2]
potassium channel, subfamily K, member 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
potassium channel, subfamily K, member 7,UP_SEQ_FEATURE[850040058$chain:Potassium channel subfamily K member 7, 850105770$glycosylation site:N-linked (GlcNAc...), 850114080$region of interest:Pore-forming 1, 850114082$region of interest:Pore-forming 2, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
potassium voltage-gated channel, Isk-related family, member 3,INTERPRO[450004884$IPR005426:Potassium channel, voltage-dependent, beta subunit, KCNE3]
potassium voltage-gated channel, Isk-related family, member 3,OMIM_DISEASE[520002519$Hypokalemic periodic paralysis]
potassium voltage-gated channel, Isk-related family, member 3,SP_PIR_KEYWORDS[790000207$Brugada syndrome, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001212$polymorphism, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
potassium voltage-gated channel, Isk-related family, member 3,UP_SEQ_FEATURE[850040176$chain:Potassium voltage-gated channel subfamily E member 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
proline rich 14,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
proline rich 14,UP_SEQ_FEATURE[850044601$chain:Proline-rich protein 14, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117295$sequence variant]
prostaglandin D2 synthase, hematopoietic; prostaglandin D2 synthase 21kDa (brain),BIOCARTA[30000093$h_eicosanoidPathway:Eicosanoid Metabolism]
prostaglandin D2 synthase, hematopoietic; prostaglandin D2 synthase 21kDa (brain),INTERPRO[450000483$IPR000566:Lipocalin-related protein and Bos/Can/Equ allergen, 450002086$IPR002345:Lipocalin, 450002618$IPR002972:Prostaglandin D synthase, 450003562$IPR004045:Glutathione S-transferase, N-terminal, 450011355$IPR012674:Calycin]
prostaglandin D2 synthase, hematopoietic; prostaglandin D2 synthase 21kDa (brain),KEGG_PATHWAY[470038780$hsa00590:Arachidonic acid metabolism]
prostaglandin D2 synthase, hematopoietic; prostaglandin D2 synthase 21kDa (brain),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000542$Fatty acid biosynthesis, 790000616$glycoprotein, 790000624$golgi apparatus, 790000792$intramolecular oxidoreductase, 790000810$Isomerase, 790000874$lipid synthesis, 790000919$membrane, 790001065$nucleus, 790001212$polymorphism, 790001249$prostaglandin biosynthesis, 790001363$Secreted, 790001405$signal, 790001547$transferase, 790001558$transport]
prostaglandin D2 synthase, hematopoietic; prostaglandin D2 synthase 21kDa (brain),UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850023258$chain:Hematopoietic prostaglandin D synthase, 850044724$chain:Prostaglandin-H2 D-isomerase, 850102883$disulfide bond, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
protease, serine, 36,INTERPRO[450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450015650$IPR017326:Polyserase-2, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
protease, serine, 36,PIR_SUPERFAMILY[630029501$PIRSF037933:polyserase-2]
protease, serine, 36,SMART[760000013$SM00020:Tryp_SPc]
protease, serine, 36,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000743$hydrolase, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001383$Serine protease, 790001405$signal, 790001652$zymogen]
protease, serine, 36,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850039968$chain:Polyserase-2, 850102883$disulfide bond, 850104965$domain:Peptidase S1 1, 850104966$domain:Peptidase S1 2, 850104967$domain:Peptidase S1 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide]
ras homolog gene family, member F (in filopodia),INTERPRO[450001599$IPR001806:Ras GTPase, 450003145$IPR003578:Ras small GTPase, Rho type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras]
ras homolog gene family, member F (in filopodia),PIR_SUPERFAMILY[630028684$PIRSF037169:small GTPase, Rho type]
ras homolog gene family, member F (in filopodia),SMART[760000148$SM00174:RHO]
ras homolog gene family, member F (in filopodia),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation]
ras homolog gene family, member F (in filopodia),UP_SEQ_FEATURE[850057601$chain:Rho-related GTP-binding protein RhoF, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117441$short sequence motif:Effector region, 850118574$splice variant]
retinoblastoma-like 1 (p107),BBID[10000001$1.RBphosphoE2F, 10000083$62.G1-phase_progression_by_Myc]
retinoblastoma-like 1 (p107),BIOCARTA[30000059$h_cellcyclePathway:Cyclins and Cell Cycle Regulation, 30000108$h_etsPathway:METS affect on Macrophage Differentiation]
retinoblastoma-like 1 (p107),INTERPRO[450002412$IPR002719:Retinoblastoma-associated protein, B-box, 450002413$IPR002720:Retinoblastoma-associated protein, A-box, 450006082$IPR006670:Cyclin, 450012382$IPR013763:Cyclin-related]
retinoblastoma-like 1 (p107),KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038850$hsa04350:TGF-beta signaling pathway]
retinoblastoma-like 1 (p107),PIR_SUPERFAMILY[630028971$PIRSF037408:retinoblastoma-like protein]
retinoblastoma-like 1 (p107),SMART[760000337$SM00385:CYCLIN]
retinoblastoma-like 1 (p107),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000258$cell cycle, 790000311$chromatin regulator, 790000356$complete proteome, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001580$tumor suppressor]
retinoblastoma-like 1 (p107),UP_SEQ_FEATURE[850057392$chain:Retinoblastoma-like protein 1, 850106258$modified residue, 850106259$mutagenesis site, 850111507$region of interest:Domain A, 850111509$region of interest:Domain B, 850114064$region of interest:Pocket; binds T and E1A, 850114683$region of interest:Spacer, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ribosomal protein S25 pseudogene 8; ribosomal protein S25,INTERPRO[450004446$IPR004977:Ribosomal protein S25]
ribosomal protein S25 pseudogene 8; ribosomal protein S25,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein S25 pseudogene 8; ribosomal protein S25,PIR_SUPERFAMILY[630002279$PIRSF002150:ribosomal protein S25]
ribosomal protein S25 pseudogene 8; ribosomal protein S25,SP_PIR_KEYWORDS[790000012$acetylation, 790000189$blocked amino end, 790000356$complete proteome, 790000445$direct protein sequencing, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome]
ribosomal protein S25 pseudogene 8; ribosomal protein S25,UP_SEQ_FEATURE[850002013$chain:40S ribosomal protein S25, 850106258$modified residue]
ring finger protein 213,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450003154$IPR003593:ATPase, AAA+ type, core, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
ring finger protein 213,SMART[760000158$SM00184:RING, 760000335$SM00382:AAA]
ring finger protein 213,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001648$zinc, 790001651$zinc-finger]
ring finger protein 213,UP_SEQ_FEATURE[850045027$chain:Protein ALO17, 850058208$chain:RING finger protein 213, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118911$zinc finger region:RING-type]
ring finger protein 8,INTERPRO[450000219$IPR000253:Forkhead-associated, 450001628$IPR001841:Zinc finger, RING-type, 450015659$IPR017335:E3 ubiquitin ligase, RNF8, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
ring finger protein 8,PIR_SUPERFAMILY[630029522$PIRSF037950:E3 ubiquitin-protein ligase RNF8, 630029523$PIRSF037950:E3_ubiquit_lig_RNF8]
ring finger protein 8,SMART[760000158$SM00184:RING, 760000212$SM00240:FHA]
ring finger protein 8,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000311$chromatin regulator, 790000315$chromosomal protein, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000859$ligase, 790000937$metal-binding, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
ring finger protein 8,UP_SEQ_FEATURE[850016728$chain:E3 ubiquitin-protein ligase RNF8, 850102485$compositionally biased region:Gln-rich, 850103775$domain:FHA, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118911$zinc finger region:RING-type]
selenoprotein N, 1,INTERPRO[450016534$IPR018249:EF-HAND 2]
selenoprotein N, 1,OMIM_DISEASE[520003443$Muscular dystrophy, rigid spine, 1]
selenoprotein N, 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000425$desmin-related myopathy, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000919$membrane, 790001368$selenium, 790001370$selenocysteine, 790001405$signal]
selenoprotein N, 1,UP_SEQ_FEATURE[850059266$chain:Selenoprotein N, 850102378$compositionally biased region:Ala-rich, 850103571$domain:EF-hand, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
septin 1,COG_ONTOLOGY[90000026$Cell division and chromosome partitioning / Cytoskeleton]
septin 1,INTERPRO[450000032$IPR000038:Cell division/GTP binding protein, 450014812$IPR016491:Septin]
septin 1,PIR_SUPERFAMILY[630006657$PIRSF006698:Septin]
septin 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
septin 1,UP_SEQ_FEATURE[850000386$binding site:GTP, 850000388$binding site:GTP; via amide nitrogen and carbonyl oxygen, 850059449$chain:Septin-1, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
similar to AAA-ATPase  TOB3; ATPase family, AAA domain containing 3B,COG_ONTOLOGY[90000108$Secondary metabolites biosynthesis, transport, and catabolism / Transcription]
similar to AAA-ATPase  TOB3; ATPase family, AAA domain containing 3B,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core]
similar to AAA-ATPase  TOB3; ATPase family, AAA domain containing 3B,SMART[760000335$SM00382:AAA]
similar to AAA-ATPase  TOB3; ATPase family, AAA domain containing 3B,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790001063$nucleotide-binding, 790001212$polymorphism]
similar to AAA-ATPase  TOB3; ATPase family, AAA domain containing 3B,UP_SEQ_FEATURE[850006788$chain:ATPase family AAA domain-containing protein 3B, 850102580$compositionally biased region:Poly-Pro, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),INTERPRO[450006867$IPR007513:Four F5 protein]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),UP_SEQ_FEATURE[850060991$chain:Small EDRK-rich factor 1, 850118574$splice variant]
solute carrier family 2 (facilitated glucose transporter), member 7,INTERPRO[450002166$IPR002442:Fructose transporter, type 5 (GLUT5), 450003208$IPR003663:Sugar/inositol transporter, 450005275$IPR005828:General substrate transporter, 450005276$IPR005829:Sugar transporter, conserved site]
solute carrier family 2 (facilitated glucose transporter), member 7,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001457$sugar transport, 790001555$transmembrane, 790001558$transport]
solute carrier family 2 (facilitated glucose transporter), member 7,UP_SEQ_FEATURE[850061382$chain:Solute carrier family 2, facilitated glucose transporter member 7, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 31 (copper transporters), member 1,INTERPRO[450006641$IPR007274:Ctr copper transporter]
solute carrier family 31 (copper transporters), member 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000371$copper, 790000373$copper transport, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
solute carrier family 31 (copper transporters), member 1,UP_SEQ_FEATURE[850023674$chain:High affinity copper uptake protein 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
sorting nexin family member 30,COG_ONTOLOGY[90000081$Intracellular trafficking and secretion / General function prediction only]
sorting nexin family member 30,INTERPRO[450001492$IPR001683:Phox-like]
sorting nexin family member 30,SMART[760000282$SM00312:PX]
sorting nexin family member 30,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
sorting nexin family member 30,UP_SEQ_FEATURE[850061556$chain:Sorting nexin-30, 850105129$domain:PX, 850106258$modified residue, 850117295$sequence variant]
synaptogyrin 1,INTERPRO[450007548$IPR008253:Marvel, 450014901$IPR016579:Synaptogyrin]
synaptogyrin 1,PIR_SUPERFAMILY[630009672$PIRSF011282:synaptogyrin]
synaptogyrin 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000263$cell junction, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001475$synapse, 790001555$transmembrane]
synaptogyrin 1,UP_SEQ_FEATURE[850063173$chain:Synaptogyrin-1, 850104755$domain:MARVEL, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
synaptotagmin VI,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450001391$IPR001565:Synaptotagmin, 450016334$IPR018029:C2 membrane targeting protein]
synaptotagmin VI,PIR_SUPERFAMILY[630002502$PIRSF002385:B/K protein/synaptotagmin]
synaptotagmin VI,SMART[760000211$SM00239:C2]
synaptotagmin VI,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000263$cell junction, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000919$membrane, 790000937$metal-binding, 790001304$repeat, 790001475$synapse, 790001555$transmembrane]
synaptotagmin VI,UP_SEQ_FEATURE[850063215$chain:Synaptotagmin-6, 850103200$domain:C2 1, 850103201$domain:C2 2, 850105910$metal ion-binding site:Calcium 1, 850105915$metal ion-binding site:Calcium 1; via carbonyl oxygen, 850105918$metal ion-binding site:Calcium 2, 850105925$metal ion-binding site:Calcium 3, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118606$topological domain:Vesicular, 850118623$transmembrane region]
tandem C2 domains, nuclear,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450016334$IPR018029:C2 membrane targeting protein]
tandem C2 domains, nuclear,SMART[760000211$SM00239:C2]
tandem C2 domains, nuclear,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
tandem C2 domains, nuclear,UP_SEQ_FEATURE[850063516$chain:Tandem C2 domains nuclear protein, 850103199$domain:C2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
testis-specific serine kinase 6,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450014172$IPR015737:Testis-specific serine-threonine kinase, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
testis-specific serine kinase 6,PIR_SUPERFAMILY[630029841$PIRSF038233:testis-specific serine/threonine-protein kinase]
testis-specific serine kinase 6,SMART[760000193$SM00220:S_TKc]
testis-specific serine kinase 6,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001388$serine/threonine-protein kinase, 790001426$spermatogenesis, 790001547$transferase]
testis-specific serine kinase 6,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850063910$chain:Testis-specific serine/threonine-protein kinase 6, 850105086$domain:Protein kinase, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP]
thymidine kinase 1, soluble,BBID[10000001$1.RBphosphoE2F]
thymidine kinase 1, soluble,INTERPRO[450001118$IPR001267:Thymidine kinase]
thymidine kinase 1, soluble,KEGG_PATHWAY[470038744$hsa00240:Pyrimidine metabolism, 470038810$hsa00983:Drug metabolism]
thymidine kinase 1, soluble,PIR_SUPERFAMILY[630027442$PIRSF035805:thymidine kinase, 630027443$PIRSF035805:TK_cell]
thymidine kinase 1, soluble,SP_PIR_KEYWORDS[790000002$3d-structure, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000450$DNA biosynthesis, 790000465$dna synthesis, 790000825$kinase, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001547$transferase]
thymidine kinase 1, soluble,UP_SEQ_FEATURE[850064433$chain:Thymidine kinase, cytosolic, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
transferrin receptor 2,INTERPRO[450002761$IPR003137:Protease-associated PA, 450006727$IPR007365:Transferrin receptor-like, dimerisation, 450006838$IPR007484:Peptidase M28]
transferrin receptor 2,OMIM_DISEASE[520002253$Hemochromatosis, type 3]
transferrin receptor 2,PIR_SUPERFAMILY[630002664$PIRSF002548:transferrin receptor]
transferrin receptor 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane]
transferrin receptor 2,UP_SEQ_FEATURE[850065735$chain:Transferrin receptor protein 2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117444$short sequence motif:Endocytosis signal, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
tubby like protein 4,INTERPRO[450000005$IPR000007:Tubby, C-terminal, 450001330$IPR001496:SOCS protein, C-terminal, 450001490$IPR001680:WD40 repeat, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
tubby like protein 4,PIR_SUPERFAMILY[630018319$PIRSF022274:tubby-like protein TUSP with WD40/SOCS domains]
tubby like protein 4,SMART[760000225$SM00253:SOCS, 760000289$SM00320:WD40]
tubby like protein 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway, 790001638$wd repeat]
tubby like protein 4,UP_SEQ_FEATURE[850067076$chain:Tubby-related protein 4, 850105375$domain:SOCS box, 850114980$region of interest:TUB, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide,BIOCARTA[30000004$h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis, 30000014$h_aktPathway:AKT Signaling Pathway, 30000030$h_badPathway:Regulation of BAD phosphorylation, 30000054$h_cdc25Pathway:cdc25 and chk1 Regulatory Pathway in response to DNA damage, 30000121$h_g2Pathway:Cell Cycle: G2/M Checkpoint, 30000135$h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK), 30000148$h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation, 30000189$h_MITRPathway:Signal Dependent Regulation of Myogenesis by Corepressor MITR, 30000226$h_pgc1aPathway:Regulation of PGC-1a, 30000233$h_plk3Pathway:Regulation of cell cycle progression by Plk3, 30000256$h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage]
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide,INTERPRO[450000264$IPR000308:14-3-3 protein]
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide,KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038835$hsa04114:Oocyte meiosis, 470038877$hsa04722:Neurotrophin signaling pathway]
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide,PIR_SUPERFAMILY[630001004$PIRSF000868:14-3-3, 630001005$PIRSF000868:14-3-3 protein]
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide,SMART[760000089$SM00101:14_3_3]
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein]
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide,UP_SEQ_FEATURE[850000891$chain:14-3-3 protein eta, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118320$site:Interaction with phosphoserine on interacting protein, 850118624$turn]
ubiquitin specific peptidase 2,INTERPRO[450001239$IPR001394:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, 450016487$IPR018200:Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2, conserved site]
ubiquitin specific peptidase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001212$polymorphism, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway]
ubiquitin specific peptidase 2,UP_SEQ_FEATURE[850067964$chain:Ubiquitin carboxyl-terminal hydrolase 2, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
vacuolar protein sorting 33 homolog A (S. cerevisiae),COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
vacuolar protein sorting 33 homolog A (S. cerevisiae),INTERPRO[450001435$IPR001619:Sec1-like protein]
vacuolar protein sorting 33 homolog A (S. cerevisiae),PIR_SUPERFAMILY[630029847$PIRSF038240:vacuolar protein sorting-associated protein 33]
vacuolar protein sorting 33 homolog A (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000501$endosome, 790000897$lysosome, 790000919$membrane, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
vacuolar protein sorting 33 homolog A (S. cerevisiae),UP_SEQ_FEATURE[850099933$chain:Vacuolar protein sorting-associated protein 33A, 850117295$sequence variant]
vanin 3,INTERPRO[450002644$IPR003010:Nitrilase/cyanide hydratase and apolipoprotein N-acyltransferase, 450010895$IPR012101:Biotinidase, eukaryotic]
vanin 3,PIR_SUPERFAMILY[630010108$PIRSF011861:Biotinidase]
vanin 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000628$gpi-anchor, 790000743$hydrolase, 790000881$lipoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal]
vanin 3,UP_SEQ_FEATURE[850100080$chain:Vascular non-inflammatory molecule 3, 850103370$domain:CN hydrolase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105861$lipid moiety-binding region:GPI-anchor amidated serine, 850109701$propeptide:Removed in mature form, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
zinc finger CCCH-type containing 12D,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000498$Endonuclease, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001049$nuclease, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
zinc finger CCCH-type containing 12D,UP_SEQ_FEATURE[850043587$chain:Probable ribonuclease ZC3H12D, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118751$zinc finger region:C3H1-type]
zinc finger and BTB domain containing 5,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006475$IPR007087:Zinc finger, C2H2-type, 450010229$IPR011333:BTB/POZ fold, 450011722$IPR013069:BTB/POZ, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger and BTB domain containing 5,SMART[760000197$SM00225:BTB, 760000323$SM00355:ZnF_C2H2]
zinc finger and BTB domain containing 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger and BTB domain containing 5,UP_SEQ_FEATURE[850101253$chain:Zinc finger and BTB domain-containing protein 5, 850103177$domain:BTB, 850106258$modified residue, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118708$zinc finger region:C2H2-type 2; atypical]
zinc finger protein 642,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 642,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 642,PIR_SUPERFAMILY[630005483$PIRSF005559:zinc finger protein ZFP-36]
zinc finger protein 642,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 642,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 642,UP_SEQ_FEATURE[850101818$chain:Zinc finger protein 642, 850104552$domain:KRAB, 850105271$domain:SCAN box, 850117294$sequence conflict, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger, DHHC-type containing 18,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger, DHHC-type containing 18,INTERPRO[450001416$IPR001594:Zinc finger, DHHC-type]
zinc finger, DHHC-type containing 18,PIR_SUPERFAMILY[630029026$PIRSF037457:palmitoyltransferase, ZDHHC9 type]
zinc finger, DHHC-type containing 18,SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000356$complete proteome, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001547$transferase, 790001555$transmembrane, 790001648$zinc, 790001651$zinc-finger]
zinc finger, DHHC-type containing 18,UP_SEQ_FEATURE[850000145$active site:S-palmitoyl cysteine intermediate, 850036755$chain:Palmitoyltransferase ZDHHC18, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850118623$transmembrane region, 850118801$zinc finger region:DHHC-type]
